Key facts
- Notable investors include 1780 Capital, Reynolda Equity Partners.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Conquest Research
- ·The full record, as it builds
Funding rounds
No funding rounds for Conquest Research are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Conquest Research
Provider of clinical research services intended to serve healthcare practices and pharmaceutical companies. The company researches various diseases related to dermatology, gastrointestinal disorders, metabolic disorders, neurology, orthopaedics, and rheumatology, among others, enabling medical professionals to discover treatment options in a cost-effective and timely manner.
- Sector
- Healthcare
- HQ
- Winter Park, FL, United States
- Founded
- 2018
- Employees
- 78
- Website
- conquestresearch.com/
- Ownership
- Privately Held (backing)
Conquest Research doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Conquest Research shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Conquest Research in its N-PORT filings yet. We sweep new filings monthly.